The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a ...

Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...

The investigation also highlights the companies' failure to adequately protect users, particularly children and teenagers.

The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...

The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other ...

Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...

Under the FOCAL plan, federal agencies have been urged to prioritize asset management, vulnerability management, defensible ...